全文获取类型
收费全文 | 958篇 |
免费 | 66篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 33篇 |
妇产科学 | 7篇 |
基础医学 | 179篇 |
口腔科学 | 68篇 |
临床医学 | 107篇 |
内科学 | 190篇 |
皮肤病学 | 11篇 |
神经病学 | 97篇 |
特种医学 | 59篇 |
外科学 | 92篇 |
综合类 | 3篇 |
预防医学 | 77篇 |
眼科学 | 3篇 |
药学 | 59篇 |
中国医学 | 1篇 |
肿瘤学 | 41篇 |
出版年
2023年 | 12篇 |
2022年 | 7篇 |
2021年 | 16篇 |
2020年 | 17篇 |
2019年 | 19篇 |
2018年 | 20篇 |
2017年 | 11篇 |
2016年 | 20篇 |
2015年 | 28篇 |
2014年 | 38篇 |
2013年 | 44篇 |
2012年 | 60篇 |
2011年 | 65篇 |
2010年 | 33篇 |
2009年 | 32篇 |
2008年 | 54篇 |
2007年 | 47篇 |
2006年 | 41篇 |
2005年 | 40篇 |
2004年 | 30篇 |
2003年 | 40篇 |
2002年 | 35篇 |
2001年 | 12篇 |
2000年 | 14篇 |
1999年 | 14篇 |
1998年 | 13篇 |
1996年 | 6篇 |
1994年 | 6篇 |
1993年 | 5篇 |
1992年 | 6篇 |
1991年 | 7篇 |
1990年 | 7篇 |
1989年 | 5篇 |
1986年 | 9篇 |
1985年 | 5篇 |
1983年 | 5篇 |
1982年 | 6篇 |
1980年 | 5篇 |
1976年 | 10篇 |
1973年 | 7篇 |
1944年 | 5篇 |
1934年 | 5篇 |
1933年 | 15篇 |
1932年 | 13篇 |
1931年 | 7篇 |
1930年 | 5篇 |
1929年 | 4篇 |
1927年 | 11篇 |
1926年 | 5篇 |
1923年 | 4篇 |
排序方式: 共有1030条查询结果,搜索用时 16 毫秒
1.
2.
3.
Else Müller-Schweinitzer 《Naunyn-Schmiedeberg's archives of pharmacology》1984,327(4):299-303
Summary Changes in tension were monitored isometrically on spiral strips from human saphenous veins obtained during surgical removal of varicose veins. Concentration-response curves for noradrenaline and 5-hydroxytryptamine (5-HT) were established by cumulative administrations, curves for dihydroergotamine were constructed from the mean responses to single concentrations. The use of the antagonists prazosin, yohimbine and pizotifen provided evidence for the existence of both postjunctional 1- and 2-adrenoceptors and for the existence of 5-HT receptors. The venoconstrictor effects of dihydroergotamine were unchanged by prazosin. Yohimbine antagonized both dihydroergotamine and 5-HT at about 60 times higher concentrations than required against noradrenaline whereas pizotifen inhibited responses to both dihydroergotamine and 5-HT at about 100 times lower concentrations than those to noradrenaline.These new results are in contrast to conclusions drawn from animal studies and do not support the suggestion that in man the venoconstrictor activity of dihydroergotamine is mediated through stimulation of -adrenoceptors. The present results strongly suggest that in human saphenous veins the constrictor activity of dihydroergotamine is mediated at least in part through stimulation of 5-HT receptors. 相似文献
4.
Else Müller-Schweinitzer 《Naunyn-Schmiedeberg's archives of pharmacology》1983,324(1):64-69
Summary The influence of the calcium antagonist nifedipine on 1- and 1-adrenoceptor vasoconstrictor effects was investigated in vitro. Changes in tension were monitored isometrically on helical strips of canine circumflex coronary and saphenous arteries suspended in 10 ml organ baths and of saphenous veins superfused with Krebs-Henseleit solution. Distinction between 1- and 2-adrenoceptor was made by using selective -adrenoceptor blocking drugs such as rauwolscine, yohimbine, corynanthine and prazosin, and the agonists noradrenaline, phenylephrine and guanfacine. In venous and both arterial vascular smooth muscles, the contractile process could be triggered by stimulation of both 1- and 2-like adrenoceptors. Nifedipine inhibited the venoconstrictor response to the 2-agonist guanfacine, leaving that to the 1-agonist phenylephrine unchanged. In saphenous arteries, nifedipine in addition to guanfacine also antagonized constrictor responses to phenylephrine, though to a significantly weaker extent. In circumflex coronary arteries, nifedipine was equally potent in antagonizing responses to both 1- and 2-adrenoceptor stimulation.It is suggested that the susceptibility of -adrenoceptormediated vasoconstrictor effects to blockade by calcium antagonists depends not only on the subtype of -adrenoceptor but, in addition, on the type and origin of vascular smooth muscle and may be a reflection of tissue variations in intracellular calcium stores. 相似文献
5.
Else Petri 《Virchows Archiv : an international journal of pathology》1944,313(1):156-157
Ohne Zusammenfassung 相似文献
6.
7.
FDG‐based quantitative comparison of glucose metabolism in vitro,exemplified by a head‐to‐head comparison between a triple‐negative breast cancer cell line and a non‐malignant foetal cell line 下载免费PDF全文
8.
Debbie Zittema Else van den Berg Esther Meijer Wendy E. Boertien Anneke C. Muller Kobold Casper F.M. Franssen Paul E. de Jong Stephan J.L. Bakker Gerjan Navis Ron T. Gansevoort 《Clinical journal of the American Society of Nephrology》2014,9(9):1553-1562
Background and objectives
Plasma copeptin, a marker of arginine vasopressin, is elevated in patients with autosomal dominant polycystic kidney disease and predicts disease progression. It is unknown whether elevated copeptin levels result from decreased kidney clearance or as compensation for impaired concentrating capacity. Data from patients with autosomal dominant polycystic kidney disease and healthy kidney donors before and after donation were used, because after donation, overall GFR decreases with a functionally normal kidney.Design, setting, participants, & measurements
Data were obtained between October of 2008 and January of 2012 from healthy kidney donors who visited the institution for routine measurements predonation and postdonation and patients with autosomal dominant polycystic kidney disease who visited the institution for kidney function measurement. Plasma copeptin levels were measured using a sandwich immunoassay, GFR was measured as 125I-iothalamate clearance, and urine concentrating capacity was measured as urine-to-plasma ratio of urea. In patients with autosomal dominant polycystic kidney disease, total kidney volume was measured with magnetic resonance imaging.Results
Patients with autosomal dominant polycystic kidney disease (n=122, age=40 years, men=56%) had significantly higher copeptin levels (median=6.8 pmol/L; interquartile range=3.4–15.7 pmol/L) compared with donors (n=134, age=52 years, men=49%) both predonation and postdonation (median=3.8 pmol/L; interquartile range=2.8–6.3 pmol/L; P<0.001; median=4.4 pmol/L; interquartile range=3.6–6.1 pmol/L; P<0.001). In donors, copeptin levels did not change after donation, despite a significant fall in GFR (from 105±17 to 66±10; P<0.001). Copeptin and GFR were significantly associated in patients with autosomal dominant polycystic kidney disease (β=−0.45, P<0.001) but not in donors. In patients with autosomal dominant polycystic kidney disease, GFR and total kidney volume were both associated significantly with urine-to-plasma ratio of urea (β=0.84, P<0.001; β=−0.51, P<0.001, respectively).Conclusions
On the basis of the finding in donors that kidney clearance is not a main determinant of plasma copeptin levels, it was hypothesized that, in patients with autosomal dominant polycystic kidney disease, kidney damage and associated impaired urine concentration capacity determine copeptin levels. 相似文献9.
10.
Luise Aamann Else Marie Vestergaard Henning Grφnbk 《World journal of gastroenterology : WJG》2014,20(12):3223-3230
Inflammatory bowel disease(IBD),which comprises ulcerative colitis and Crohn’s disease,is characterized by inflammation of the gastrointestinal tract.The trefoil factors 1,2,and 3(TFF1-3)are a family of peptides that play important roles in the protection and repair of epithelial surfaces,including the gastrointestinal tract.TFFs may be involved in IBD pathogenesis and are a potential treatment option.In the present review,we describe the TFF family and their potential role in IBD by summarizing the current knowledge of their expression,possible function and pharmacological role in IBD. 相似文献